re: News: SAI drops CEO & reveals $1.1B takeo... It never ceases to amaze what does and doesn't attract attention on HC.Well done to holders
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%